Investors and Media

Archived Press Releases

The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is as of the date of such press release. Scholar Rock undertakes no duty to update the information contained in such press release after the date of its issuance unless required by law.

Main content section

January 4, 2016

Scholar Rock Announces Appointment of Leading Fibrosis Expert Dr. Scott L. Friedman to Scientific Advisory Board

Read More

January 4, 2016

Scholar Rock Announces $36 Million Series B Financing

Read More

January 4, 2016

Scholar Rock to Present at 34th Annual J.P. Morgan Healthcare Conference

Read More

September 23, 2015

Scholar Rock Presents First Data for Niche Modulator Inhibiting Myostatin Activation and Announces SRK-015 as Lead Drug Program

Read More

July 14, 2015

Scholar Rock Presents Preclinical Data for First Demonstration of Novel Pharmacological Approach to Targeting the TGFβ1 Latent Complex

Read More

July 14, 2015

Scholar Rock Appoints Paul D. Burgess, JD, as Vice President of Intellectual Property

Read More

July 1, 2015

Scholar Rock to Present at 1st William Blair and Westwicke Partners Biotechnology Conference

Read More

May 22, 2015

Scholar Rock to Present at Jefferies 2015 Global Healthcare Conference

Read More

November 20, 2014

Scholar Rock Appoints Gregory J. Carven, PhD, as Vice President of Antibody Discovery and Protein Sciences

Read More

September 15, 2014

Scholar Rock Announces $20 Million Series A Financing

Read More